Latest News and Press Releases

IRVINE, CA, and HERSTAL, BELGIUM – July 3, 2025 (GlobeNewswire) – MDxHealth SA (NASDAQ: MDXH) (the "Company" or "mdxhealth"), a leading precision diagnostics company, today announced the appointment...

Dublin, June 12, 2025 (GLOBE NEWSWIRE) -- The "Liquid Biopsy Markets by Cancer, Usage, Biomarker, Place, & Product with Price and Volume Outlook, Including Executive and Consultant Guides...

Year-over-year Q1 revenues increase by 22% to $24.3 million71% year-over-year improvement in adjusted EBITDA in first quarterConference call with Q&A today at 4:30 PM ET / 22:30 CET IRVINE, CA,...

New York, USA, May 14, 2025 (GLOBE NEWSWIRE) -- Global Preeclampsia Diagnostics Market to Exhibit Growth at a CAGR of ~4% by 2032 | DelveInsight The expansion of the preeclampsia diagnostics market...

New York, USA, May 08, 2025 (GLOBE NEWSWIRE) -- Global Immunodiagnostics Market to Cross the USD 32 Billion by 2032 | DelveInsight The growing prevalence of chronic and infectious diseases is a...

New York, USA, May 01, 2025 (GLOBE NEWSWIRE) -- Global Molecular Diagnostics Market to Expand at a CAGR of ~9% by 2032 Due to the Rising Demand for Precision Medicine | DelveInsight The molecular...

Company to Host Conference Call with Live Q&A, May 14, 2025, at 4:30pm ET / 22:30 CET IRVINE, California – April 30, 2025 (GlobeNewswire) – MDxHealth SA (NASDAQ: MDXH), a leading precision...

Austin, April 18, 2025 (GLOBE NEWSWIRE) -- Prostate Cancer Diagnostics Market Size & Growth Analysis: According to a new research report by SNS Insider, the global Prostate Cancer Diagnostics...

New York, USA, April 16, 2025 (GLOBE NEWSWIRE) -- Global In-Vitro Diagnostics Market Predicted to Surpass the USD 90 Billion Mark by 2032 | DelveInsight The in-vitro diagnostics market is projected...

Fourth quarter revenue growth of 28% to $24.7 million2024 revenue growth of 28% to $90.0 million68% improvement in adjusted EBITDA in fourth quarterConference call with Q&A today at 4:30 PM EST /...